Potentiating hypoxic microenvironment for antibiotic activation by photodynamic therapy to combat bacterial biofilm infections
Traditional antibiotic treatment has limited efficacy for the drug-tolerant bacteria present in biofilms because of their unique metabolic conditions in the biofilm infection microenvironment. Modulating the biofilm infection microenvironment may influence the metabolic state of the bacteria and pro...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Research
2022
|
Online Access: | View Fulltext in Publisher |
LEADER | 01899nam a2200229Ia 4500 | ||
---|---|---|---|
001 | 10.1038-s41467-022-31479-x | ||
008 | 220718s2022 CNT 000 0 und d | ||
020 | |a 20411723 (ISSN) | ||
245 | 1 | 0 | |a Potentiating hypoxic microenvironment for antibiotic activation by photodynamic therapy to combat bacterial biofilm infections |
260 | 0 | |b Nature Research |c 2022 | |
856 | |z View Fulltext in Publisher |u https://doi.org/10.1038/s41467-022-31479-x | ||
520 | 3 | |a Traditional antibiotic treatment has limited efficacy for the drug-tolerant bacteria present in biofilms because of their unique metabolic conditions in the biofilm infection microenvironment. Modulating the biofilm infection microenvironment may influence the metabolic state of the bacteria and provide alternative therapeutic routes. In this study, photodynamic therapy is used not only to eradicate methicillin-resistant Staphylococcus aureus biofilms in the normoxic condition, but also to potentiate the hypoxic microenvironment, which induces the anaerobic metabolism of methicillin-resistant Staphylococcus aureus and activates the antibacterial activity of metronidazole. Moreover, the photodynamic therapy-activated chemotherapy can polarize the macrophages to a M2-like phenotype and promote the repair of the biofilm infected wounds in mice. This biofilm infection microenvironment modulation strategy, whereby the hypoxic microenvironment is potentiated to synergize photodynamic therapy with chemotherapy, provides an alternative pathway for efficient treatment of biofilm-associated infections. © 2022, The Author(s). | |
700 | 1 | |a Dong, H. |e author | |
700 | 1 | |a Li, X. |e author | |
700 | 1 | |a Mou, Y. |e author | |
700 | 1 | |a Wan, L. |e author | |
700 | 1 | |a Wang, L. |e author | |
700 | 1 | |a Xiu, W. |e author | |
700 | 1 | |a Yang, D. |e author | |
700 | 1 | |a Yang, K. |e author | |
700 | 1 | |a Yuwen, L. |e author | |
773 | |t Nature Communications |